Clover Health Investments, Corp. (CLOV) vs Recursion Pharmaceuticals, Inc. (RXRX)
A side-by-side comparison of Clover Health Investments, Corp. and Recursion Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLOV
Clover Health Investments, Corp.
$4.68HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
RXRX
Recursion Pharmaceuticals, Inc.
$4.78HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CLOV vs RXRX
growth of $100 · dividends reinvested · last 5yCLOV -36.2% (-8.6%/yr)RXRX -73.4% (-23.3%/yr)CLOV compounded faster over this window
CLOV RXRX
CLOV vs RXRX: by the numbers
- •RXRX is the larger company ($2.51B vs $2.43B market cap).
- •Both run net losses; CLOV's is the smaller (-0.74% vs -945.92% net margin).
- •RXRX grew revenue faster over the past five years (45.50% vs 21.18% CAGR).
Metrics side by side
Valuation
| Metric | CLOV | RXRX |
|---|---|---|
| Forward P/E | 83.51 | N/A |
| P/S ratio | 0.98 | 45.72 |
| P/B ratio | 6.45 | 2.74 |
| FCF yield | 3.06% | N/A |
Profitability
| Metric | CLOV | RXRX |
|---|---|---|
| Gross margin | 18.57% | -61.96% |
| Operating margin | -0.74% | -867.87% |
| Net margin | -0.74% | -945.92% |
| ROE | -4.88% | -56.71% |
| ROIC | -4.62% | -49.78% |
Growth (annualized)
| Metric | CLOV | RXRX |
|---|---|---|
| Revenue CAGR (5Y) | 21.18% | 45.50% |
| Total return CAGR (5Y) | -8.36% | -25.86% |
Frequently asked
- Which has grown faster, CLOV or RXRX?
- Over the past five years, RXRX grew revenue faster — CLOV at a 21.18% CAGR versus RXRX at 45.50%.
- How have CLOV and RXRX total returns compared?
- Over the past 5 years, CLOV delivered -8.36% and RXRX delivered -25.86% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Clover Health Investments ROERecursion Pharmaceuticals ROEClover Health Investments operating marginRecursion Pharmaceuticals operating marginClover Health Investments revenue growthRecursion Pharmaceuticals revenue growthClover Health Investments free cash flowRecursion Pharmaceuticals free cash flow
Clover Health Investments & Recursion Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.